Sarosh R Irani Selected Research

Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)

1/2022	Assessment of apathy in neurological patients using the Apathy Motivation Index caregiver version.
3/2021	Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management.
10/2020	Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.
1/2020	Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
1/2019	Hippocampal network abnormalities explain amnesia after VGKCC-Ab related autoimmune limbic encephalitis.
1/2018	The importance of early immunotherapy in patients with faciobrachial dystonic seizures.
5/2017	Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis.
1/2017	Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.
2/2015	The active intrathecal B-cell response in LGI1-antibody encephalitis.
10/2013	Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarosh R Irani Research Topics

Disease

28	Encephalitis (Encephalitis, Rasmussen) 11/2022 - 11/2009
20	Glioma (Gliomas) 11/2022 - 09/2010
18	Seizures (Absence Seizure) 11/2022 - 04/2011
15	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2022 - 04/2010
11	Autoimmune Diseases of the Nervous System 10/2022 - 04/2016
11	Epilepsy (Aura) 01/2021 - 04/2010
10	Neoplasms (Cancer) 02/2022 - 10/2010
9	Brain Diseases (Brain Disorder) 01/2020 - 06/2010
8	Neuromyelitis Optica (Devic's Disease) 05/2022 - 07/2015
7	Movement Disorders (Movement Disorder) 05/2021 - 06/2011
5	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 06/2014
5	Isaacs Syndrome (Neuromyotonia) 10/2020 - 09/2010
4	Amnesia (Dissociative Amnesia) 11/2022 - 01/2018
4	Cognitive Dysfunction 01/2022 - 05/2011
4	Myasthenia Gravis 01/2022 - 01/2019
4	Psychotic Disorders (Schizoaffective Disorder) 11/2021 - 06/2011
4	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021 - 11/2012
4	Central Nervous System Diseases (CNS Diseases) 01/2020 - 08/2014
3	Inflammation (Inflammations) 11/2021 - 01/2018
3	Neuralgia (Stump Neuralgia) 10/2021 - 01/2016
3	Pain (Aches) 10/2021 - 12/2018
3	Multiple Sclerosis 05/2020 - 10/2017
3	Atrophy 01/2019 - 05/2011
3	Temporal Lobe Epilepsy 01/2019 - 06/2010
3	Thymoma (Thymic Carcinoma) 12/2018 - 10/2010
3	Infections 01/2018 - 05/2011
2	Teratoma (Teratoid Tumor) 01/2022 - 01/2018
2	Ovarian Teratoma 01/2022 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 04/2010
2	Optic Neuritis (Retrobulbar Neuritis) 01/2021 - 10/2017
2	Dyskinesias (Dyskinesia) 01/2021 - 01/2018
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2020 - 04/2010
2	Lymphocytosis 01/2020 - 06/2010
2	Myoclonus (Nocturnal Myoclonus) 01/2020 - 11/2019
2	Nervous System Diseases (Neurological Disorders) 11/2019 - 01/2019
2	Stiff-Person Syndrome (Stiff Man Syndrome) 11/2019 - 01/2018
2	Myelitis 05/2018 - 10/2017
2	Chorea (Rheumatic Chorea) 01/2018 - 07/2012
2	Sporadic Creutzfeldt-Jakob Disease 02/2016 - 09/2012
2	Hyponatremia 08/2012 - 05/2011
1	Meningoencephalitis 10/2022
1	Tertiary Lymphoid Structures 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Anhedonia 01/2022
1	POEMS Syndrome (Syndrome, POEMS) 12/2021
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 12/2021
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 11/2021
1	Transverse Myelitis (Necrotizing Myelitis) 01/2021
1	Hypoventilation 01/2021
1	Fatigue 01/2021
1	Partial Epilepsies (Epilepsy, Partial) 01/2021
1	Disease Progression 01/2021

Drug/Important Bio-Agent (IBA)

48	AntibodiesIBA 10/2022 - 11/2009
46	AutoantibodiesIBA 11/2022 - 04/2010
20	Leucine (L-Leucine)FDA Link 11/2022 - 09/2010
19	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2010
18	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 11/2009
14	AntigensIBA 10/2022 - 02/2015
14	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2019 - 04/2010
11	Immunoglobulin G (IgG)IBA 01/2022 - 02/2015
9	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 10/2021 - 05/2011
6	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021 - 06/2014
4	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 04/2010
4	Glycine Receptors (Glycine Receptor)IBA 01/2020 - 08/2011
4	N-Methylaspartate (NMDA)IBA 01/2018 - 06/2010
3	Pharmaceutical PreparationsIBA 01/2021 - 10/2013
3	Oligoclonal BandsIBA 01/2020 - 06/2010
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 02/2015
2	Aquaporins (Water Channels)IBA 01/2022 - 01/2020
2	muskIBA 01/2022 - 01/2019
2	EpitopesIBA 01/2022 - 11/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 10/2013
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2019
2	Rituximab (Mabthera)FDA Link 01/2022 - 07/2014
2	Biological ProductsIBA 10/2021 - 01/2020
2	amphiphysinIBA 01/2020 - 01/2018
2	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 08/2011
2	CytokinesIBA 01/2020 - 01/2018
2	Contactin 2IBA 12/2018 - 09/2010
2	Complement System Proteins (Complement)IBA 01/2018 - 01/2018
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 05/2011
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2018 - 06/2010
2	AMPA Receptors (AMPA Receptor)IBA 08/2011 - 04/2011
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 04/2011 - 04/2010
1	Cholinergic ReceptorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Immunoglobulin IsotypesIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	anti-NMDA receptor autoantibodyIBA 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 11/2021
1	AutoantigensIBA 10/2021
1	Surface Antigens (Surface Antigen)IBA 10/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021

Therapy/Procedure

31	Immunotherapy 01/2022 - 04/2010
3	Therapeutics 01/2020 - 01/2005
2	Immunomodulation 01/2020 - 05/2017
1	Stem Cell Transplantation 05/2022
1	Activities of Daily Living (ADL) 01/2022
1	Duration of Therapy 01/2021